Onconetix, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
ONCO$3.47-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Nine months Ended September 30, 2025 | Nine months Ended September 30, 2024 | |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | $(19,702,029) | $(29,252,681) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Loss on impairment of goodwill | 11,512,000 | 15,453,000 |
| Impairment of ENTADFI assets | — | 3,530,716 |
| Amortization of debt discounts | 120,162 | 371,578 |
| Amortization of debt discount - related party | — | 400,000 |
| Depreciation and amortization | 11,834 | 612,046 |
| Net periodic pension benefit | 353,384 | 16,502 |
| Stock-based compensation | 70,033 | 98,228 |
| Interest accrued on note payable | — | 230,532 |
| Interest accrued on note payable – related party | — | 134,247 |
| Loss on impairment of inventory of ENTADFI | — | 356,637 |
| Loss on extinguishment of notes payable | 5,384,719 | — |
| Loss on extinguishment of Series C preferred stock | 196,244 | — |
| Loss on issuance of Series D preferred stock | 2,543,329 | — |
| Change in fair value of contingent warrant liabilities | 10,060 | (35,730) |
| Change in fair value of warrant liabilities | (1,934,000) | — |
| Change in fair value of derivative liabilities | 216,000 | — |
| Change in fair value of subscription agreement liability – related party | (3,127,962) | 950,000 |
| Gain on forgiveness of accounts payable | (944,694) | — |
| Deferred tax benefit | — | (127,183) |
| Loss on disposal of property and equipment | 17,033 | — |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 25,244 | 49,079 |
| Inventories | (74,182) | (113,102) |
| Prepaid expenses and other current assets | 370,868 | 70,563 |
| Prepaid expenses, long-term | — | (7,749) |
| Deferred offering costs | (150,000) | — |
| Accounts payable | (1,047,968) | (1,242,071) |
| Accrued expenses | (437,882) | (1,072,781) |
| Net cash used in operating activities | (6,587,805) | (9,578,169) |
| Cash flows from investing activities | ||
| Purchases of property and equipment | — | (24,597) |
| Net cash Provided by (used in) investing activities | — | (24,597) |
| Cash flows from financing activities | ||
| Proceeds from issuance of note payable – related party | — | 5,000,000 |
| Proceeds from issuance of note payable | 875,000 | 853,550 |
| Payment of financing costs | — | (400,000) |
| Principal payments of notes payable | (6,947,360) | (942,307) |
| Proceeds from exercise of preferred investment options, net | — | 922,749 |
| Payment for redemption of Series C Preferred Stock | (1,713,570) | — |
| Proceeds from exercise of stock options | — | 163 |
| Proceeds from exercise of warrants | — | 6,155 |
| Proceeds from issuance of Series D preferred stock and warrants | 9,301,200 | — |
| Proceeds from sale of common stock | 6,391,634 | — |
| Cash in lieu of shares | (926) | — |
| Net cash provided by financing activities | 7,905,978 | 5,440,310 |
| Effect of exchange rate changes on cash | (1,128,117) | (50,384) |
| Net increase (decrease) in cash | 190,056 | (4,212,840) |
| Cash, beginning of period | 646,500 | 4,554,335 |
| Cash, end of period | $836,556 | $341,495 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $188,313 | $19,658 |
| Noncash investing and financing activities: | ||
| Incremental fair value of exchanged preferred investment options | $— | $1,874,777 |
| Recognition of contingent warrant liabilities | $— | $157,720 |
| Conversion of Series A Preferred Stock to common stock | $— | $1 |
| Conversion of Series B Preferred Stock to common stock | $— | $64,236,085 |
| Settlement of related party note payable and accrued interest through issuance of common stock | $— | $5,134,247 |
| Operating right-of-use asset obtained in exchange of lease liability | $— | $87,864 |
| D&O insurance premium financed | $460,875 | $— |
| Deemed dividend owed to Series C preferred stock shareholders | $409,510 | $— |
| Settlement of subscription agreement liability | $995,038 | $— |
| Conversion of Series C preferred stock to common stock | $801,241 | $— |
| Recognition of warrant liabilities | $14,749,000 | $— |
| Recognition of derivative liabilities | $772,000 | $— |
| Recognition of Series D preferred stock | $5,630,946 | $— |
| Series C preferred stock exchanged for Series D preferred stock | $246,227 | $— |
| Settlement of note payable through issuance of Series D preferred stock | $3,430,244 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.